Evaluation of different sodium bicarbonate regimens for the prevention of contrast medium-induced nephropathy

Authors

  • Sameh Abouzeid Nephrology Department, Theodor Bilharz Research Institute, Cairo, Egypt.

Keywords:

CIN, NaHCO3, coronary angiography

Abstract

Introduction: The rapid decline in renal function caused by radiographic contrast agents usually is transient, but it can result in chronic kidney disease. The pathophysiology of contrast-induced nephropathy (CIN) is poorly understood, but it may include acute hypoxia-induced oxidative stress and free radicals generated within the acid environment of the renal medulla. Thus, the alkalization of urine by sodium bicarbonate has been regarded as resulting in the reduction of CIN. The aim of this study was to determine whether a long-duration sodium bicarbonate regimen is more effective than a short-duration regimen in reducing CIN. 

Methods: One hundred patients were assigned randomly to treatment with sodium bicarbonate solution using either the short regimen (intravenous bolus 3 mL/kg/h of 166 mEq/L sodium bicarbonate for 1 hour immediately before radiocontrast) or the long regimen (initial intravenous bolus of 3 mL/kg/h of 166 mEq/L sodium bicarbonate for 6 hr). Patients with renal dysfunction (estimated glomerular filtration rate [eGFR], 60 mL/min/1.73 m2 or less) who underwent elective or emergent coronary angiography (CAG) with/without percutaneous coronary intervention (PCI) at Nephrology Department (Theodor Bilharz Research Institute) were enrolled in the study. Data were analyzed by SPSS version 12, using Kruskal Wallis, ANOVA, Chi square test and Spearman rank correlation coefficient.

Results: There was a significant increase in serum creatinine and a decrease in eGFR 48 hr post-intervention in group 1 (short regimen) with no statically difference regarding those parameters group 2 (long regimen). Serum potassium clearly was decreased significantly post procedure in both groups. 

Conclusions: The results of our study indicated that the long regimen of bicarbonate supplementation was a more effective strategy to prevent CIN than the short regimen.

 

References

Levy EM, Viscoli CM, Horwitz RI. The effect of acute renal failure on mortality. A cohort analysis. J Am

Med Assoc. 1996; 275: 1489-94. doi: 10.1001/jama.1996.03530430033035, PMID: 8622223.

Hou SH, Bushinsky DA, Wish JB, Cohen JJ, Harrington JT. Hospital-acquired renal insufficiency: a

prospective study. Am J Med. 1983; 74: 243-8. doi: 10.1016/0002-9343(83)90618-6, PMID: 6824004.

Rihal CS, Textor SC, Grill DE, Berger PB, Ting HH, Best PJ, et al. Incidence and prognostic importance of

acute renal failure after percutaneous coronary intervention. Circulation. 2002; 105: 2259-64. doi:

1161/01.CIR.0000016043.87291.33, PMID: 12010907.

Mueller C. Prevention of contrast-induced nephropathy with volume supplementation. Kidney Int Suppl.

; 69: S16-19. PMID: 16612395.

Bakris GL, Lass N, Gaber AO, Jones JD, Burnett JC Jr. Radiocontrast medium-induced declines in renal

function: a role for oxygen free radicals. Am J Physiol. 1990; 258: F115-20. PMID: 2301588.

Marenzi G, Marana I, Lauri G, Assanelli E, Grazi M, Campodonico J, et al. The prevention of

radiocontrast-agent-induced nephropathy by hemofiltration. N Engl J Med. 2003; 349: 1333-40. doi:

1056/NEJMoa023204, PMID: 14523141.

Solomon R, Werner C, Mann D, D'Elia J, Silva P. Effects of saline, mannitol, and furosemide to prevent

acute decreases in renal function induced by radiocontrast agents. N Engl J Med. 1994; 331: 1416-20. doi:

1056/NEJM199411243312104, PMID: 7969280.

Stone GW, McCullough PA, Tumlin JA, Lepor NE, Madyoon H, Murray P, et al. Fenoldopam mesylate for

the prevention of contrast-induced nephropathy: a randomized controlled trial. J Am Med Assoc. 2003;

: 2284-91. doi: 10.1001/jama.290.17.2284, PMID: 14600187.

Birck R, Krzossok S, Markowetz F, Schnulle P, van der Woude FJ, Braun C. Acetylcysteine for prevention

of contrast nephropathy: meta-analysis. Lancet. 2003; 362: 598-603. doi: 10.1016/S0140-6736(03)14189- X, PMID: 12944058.

Hoffmann U, Fischereder M, Kruger B, Drobnik W, Kramer BK. The value of N-acetylcysteine in the

prevention of radiocontrast agent-induced nephropathy seems questionable. J Am Soc Nephrol. 2004; 15:

-10. doi: 10.1097/01.ASN.0000106780.14856.55, PMID: 14747387.

Merten GJ, Burgess WP, Gray LV, Holleman JH, Roush TS, Kowalchuk GJ, et al. Prevention of contrastinduced nephropathy with sodium bicarbonate: a randomized controlled trial. JAMA. 2004; 291(19): 2328–

doi: 10.1001/jama.291.19.2328, PMID: 15150204.

Recio-Mayoral A, Chaparro M, Prado B, Cózar R, Méndez I, Banerjee D, et al. The Reno-protective effect

of hydration with sodium bicarbonate plus N-acetylcysteine in patients undergoing emergency

percutaneous coronary intervention: the RENO study. J Am Coll Cardiol. 2007; 49(12): 1283–8. doi:

1016/j.jacc.2006.11.034, PMID: 17394959.

Rihal C, Textor S, Grill D, Berger P, Ting H, Best PJ, et al. Incidence and prognostic importance of acute

renal failure after percutaneous coronary intervention. Circulation. 2002; 105: 2259–64. doi:

1161/01.CIR.0000016043.87291.33, PMID: 12010907.

Merten G, Burgess W, Gray L, Holleman J, Roush T, Kowalchuk G, et al. Prevention of contrast-induced

nephropathy with sodium bicarbonate: a randomized controlled trial. J Am Med Assoc. 2004; 291: 2328–

doi: 10.1001/jama.291.19.2328, PMID: 15150204.

Zoungas S, Ninomiya T, Huxley R, Cass A, Jardine M, Gallagher M, et al. Systematic review: sodium

bicarbonate treatment regimens for the prevention of contrast-induced nephropathy. Ann Intern Med. 2009;

: 631–8. doi: 10.7326/0003-4819-151-9-200911030-00008, PMID: 19884624.

Klima T, Christ A, Marana I, Kalbermatter S, Uthoff H, Burri E, et al. Sodium chloride vs. Sodium

bicarbonate for the prevention of contrast medium-induced nephropathy: a randomized controlled trial. Eur

Heart J. doi: 10.1093/eurheartj/ehr501, PMID: 22267245.

Briguori C, Airoldi F, D’Andrea D, Bonizzoni E, Morici N, Focaccio A, et al. Renal Insufficiency

Following Contrast Media Administration Trial (REMEDIAL): a randomized comparison of 3 preventive

strategies. Circulation. 2007; 115: 1211–7. PMID: 17309916.

Recio-Mayoral A, Chaparro M, Prado B, Cozar R, Mendez I, Banerjee D, et al. The reno-protective effect

of hydration with sodium bicarbonate plus N-acetylcysteine in patients undergoing emergency

percutaneous coronary intervention: the RENO Study. J Am Coll Cardiol. 2007; 49: 1283–8. doi:

1016/j.jacc.2006.11.034.

Walter A, Ali A, Kurt M, Carey S. Hyperkalemia Revisite. Tex Heart Inst J. 2006; 33(1): 40–7. PMCID:

PMC1413606.

Kim H. Combined effect of bicarbonate and insulin with glucose in acute therapy of hyperkalemia in end- stage renal disease patients. Nephron. 1996; 72: 476–82. doi: 10.1159/000188917, PMID: 8852501.

Published

2022-02-21